These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33839794)

  • 1. HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study.
    Yamamoto R; Jensen MK; Aroner S; Furtado JD; Rosner B; Hu FB; Balkau B; Natali A; Ferrannini E; Baldi S; Sacks FM
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2928-e2940. PubMed ID: 33839794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
    Aroner SA; Furtado JD; Sacks FM; Tsai MY; Mukamal KJ; McClelland RL; Jensen MK
    Diabetologia; 2019 Jun; 62(6):981-992. PubMed ID: 30949716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
    Yamamoto R; Sacks FM; Hu FB; Rosner B; Furtado JD; Aroner SA; Ferrannini E; Baldi S; Kozakova M; Balkau B; Natali A; Jensen MK;
    Atherosclerosis; 2018 Feb; 269():92-99. PubMed ID: 29351856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk.
    Aroner SA; Yang M; Li J; Furtado JD; Sacks FM; Tjønneland A; Overvad K; Cai T; Jensen MK
    Am J Epidemiol; 2017 Sep; 186(6):736-744. PubMed ID: 28520887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis).
    Aroner SA; Koch M; Mukamal KJ; Furtado JD; Stein JH; Tattersall MC; McClelland RL; Jensen MK
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29540426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
    Chan DC; Nguyen MN; Watts GF; Barrett PH
    J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III.
    Koch M; Furtado JD; Jiang GZ; Gray BE; Cai T; Sacks F; Tjønneland A; Overvad K; Jensen MK
    J Lipid Res; 2017 Jun; 58(6):1196-1203. PubMed ID: 28365588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
    Jensen MK; Aroner SA; Mukamal KJ; Furtado JD; Post WS; Tsai MY; Tjønneland A; Polak JF; Rimm EB; Overvad K; McClelland RL; Sacks FM
    Circulation; 2018 Mar; 137(13):1364-1373. PubMed ID: 29162611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
    J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.
    Mendivil CO; Rimm EB; Furtado J; Sacks FM
    J Am Heart Assoc; 2013 May; 2(3):e000130. PubMed ID: 23672999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
    van Capelleveen JC; Bernelot Moens SJ; Yang X; Kastelein JJP; Wareham NJ; Zwinderman AH; Stroes ESG; Witztum JL; Hovingh GK; Khaw KT; Boekholdt SM; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1206-1212. PubMed ID: 28473441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.
    Talayero B; Wang L; Furtado J; Carey VJ; Bray GA; Sacks FM
    J Lipid Res; 2014 Oct; 55(10):2167-77. PubMed ID: 24966274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome.
    Gugliucci A; Lustig RH; Caccavello R; Erkin-Cakmak A; Noworolski SM; Tai VW; Wen MJ; Mulligan K; Schwarz JM
    Atherosclerosis; 2016 Oct; 253():171-177. PubMed ID: 27451002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks.
    Onat A; Hergenç G; Ayhan E; Uğur M; Kaya H; Tuncer M; Can G
    Diabet Med; 2009 Oct; 26(10):981-8. PubMed ID: 19900229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.
    Wyler von Ballmoos MC; Haring B; Sacks FM
    J Clin Lipidol; 2015; 9(4):498-510. PubMed ID: 26228667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
    Cohn JS; Patterson BW; Uffelman KD; Davignon J; Steiner G
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3949-55. PubMed ID: 15292332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
    Rozhkova TA; Titov VN; Amelyushkina VA; Kaba SI; Kukhartchuk VV
    Klin Lab Diagn; 2015 Dec; 60(12):4-14. PubMed ID: 27032246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.